ASSAY Clinical Research

Executive Summary

ASSAY Clinical Research is a UK-based clinical research organization (CRO) specializing in innovative trial management solutions, with a focus on oncology. Founded in 2012, the company leverages emerging technologies to design efficient and effective clinical trial strategies for pharmaceutical, biotech, and medical device companies, as well as other CROs and healthcare professionals. By offering tailored services, ASSAY aims to optimize trial outcomes and reduce time-to-market for new therapies. The company is privately held and has not disclosed funding or valuation, but its specialized niche in oncology and technology-driven approach positions it well in the competitive CRO market. As the clinical trial landscape evolves, ASSAY's emphasis on emerging tech could drive growth through increased adoption of digital and AI-enabled tools.

Upcoming Catalysts (preview)

• Q3 2026Launch of AI-powered clinical trial optimization platform70% success
• Q4 2026Strategic partnership with a mid-to-large biopharma company50% success
• TBDExpansion into the US clinical trial services market40% success